| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |